NatWest Group’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-12,600
Closed -$1.36M 404
2015
Q3
$1.36M Buy
12,600
+6,929
+122% +$860K 0.03% 169
2015
Q2
$656K Sell
5,671
-7,285
-56% -$833K 0.01% 226
2015
Q1
$1.49M Buy
12,956
+1,240
+11% +$148K 0.02% 188
2014
Q4
$1.31K Buy
11,716
+4,127
+54% +$435K 0.01% 196
2014
Q3
$719 Sell
7,589
-22,663
-75% -$2.05M 0.01% 298
2014
Q2
$2.6M Buy
30,252
+22,814
+307% +$1.73M 0.11% 162
2014
Q1
$519K Sell
7,438
-69,278
-90% -$5.49M 0.02% 323
2013
Q4
$6.48M Buy
76,716
+12,962
+20% +$1.03M 0.16% 141
2013
Q3
$4.91M Sell
63,754
-151,366
-70% -$10.6M 0.14% 149
2013
Q2
$12.6M Buy
+215,120
New +$12.9M 0.18% 99

Other funds holding CELG

NatWest Group's CELG Position: Q4 2015 in Review

NatWest Group sold out of Celgene Corp (CELG) in Q4 2015, closing a stake of 12,600 shares — an estimated $1.36M sold.

NatWest Group first reported a position in CELG in Q2 2013 and held it in 10 quarters. The position peaked at $12.6M in Q2 2013. 1,246 funds tracked by Wall St. Rank hold CELG as of Q4 2015.

  • NatWest Group reported no remaining Celgene Corp position as of Q4 2015 after selling out during the quarter.
  • NatWest Group sold 12,600 Celgene Corp shares in Q4 2015, an estimated $1.36M.
  • NatWest Group first reported a position in Celgene Corp in Q2 2013 and held it in 10 quarters.
  • NatWest Group's Celgene Corp position peaked at $12.6M in Q2 2013.
  • 1,246 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.